Skip to main content

Webinar - 68Ga-PSMA : from production to clinical applications

webinar psma2021

Thursday, January 28, 2021 - 8:26

<p>Numerous clinical trials with Ga-PSMA PET/CT have demonstrated that this procedure outperforms current standard imaging for both specificity and sensitivity. It is used to detect sites of prostate cancer allowing complete evaluation of the local tumor and lymph nodes, visceral and bone metastases with high accuracy in only one examination.&nbsp;</p> <p>IBA invites you to attend a free webinar presented by 2 leading figures of Nuclear Medicine: Prof Francisco Alves and Dr Jeremie Calais.&nbsp;</p> <p>When? February 23rd, 5-6 pm CET (11-12 am EST)<br /> &nbsp;&nbsp;</p> <p><br /> <strong>What will you learn from the webinar ?&nbsp;</strong></p> <p><br /> •&nbsp;&nbsp; &nbsp; &nbsp;<sup>68</sup>Ga Production process from a cyclotron: why &amp; how? &nbsp;</p> <p>By Francisco Alves, Chief physicist &amp; head of Cyclotron at ICNAS-University of Coimbra in Portugal.&nbsp;</p> <p>Prof Alves will share his expertise on the production process of &nbsp;<sup>68</sup>Ga from cyclotron using a liquid target to labelling. He will give a financial insight on the cyclotron versus generator production based on his site experience and context.</p> <p><br /> &nbsp;&nbsp;</p> <p>•&nbsp;&nbsp; &nbsp;Diagnostic efficacy of &nbsp;<sup>68</sup>Ga-PSMA versus conventional imaging in prostate cancer patients</p> <p>By Jeremie Calais, Director of the Clinical Research Program of the Nuclear Medicine and Theranostics Division at UCLA.</p> <p>Dr. Calais will compare &nbsp;<sup>68</sup>Ga-PSMA PET-CT Imaging with conventional modalities and its impact in the management of patient with prostate cancer.&nbsp;<br /> &nbsp;&nbsp;</p> <p><a href="https://us02web.zoom.us/webinar/register/WN_P-jsGfm-SZenkQft5UeJog">Register</a></p>
Share

More news